The Commission is now operating in accordance with the Caretaker ConventionsExternal link pending the outcome of the 2025 federal election.
This document describes each of the quality statements and indicators included in the Opioid Analgesic Stewardship in Acute Pain Clinical Care Standard and their relevance to health service organisations.
This fact sheet lists the quality statements for clinicians included in the Opioid Analgesic Stewardship in Acute Pain Clinical Care Standard.
This resource for consumers explains what each quality statement in the Opioid Analgesic Stewardship in Acute Pain Clinical Care Standard means for people presenting with acute pain to the emergency department or following in-patient surgery.
To inform patients, and their family or carer, about the potential benefits and harms of acute pain treatment options so that they can participate in decision-making about their treatment with their clinician. This may or may not include opioid analgesics.
The Opioid Analgesic Stewardship in Acute Pain Clinical Care Standard was endorsed by the following organisations in 2022:
The definitions required to collect and calculate indicator data are specified in the Metadata Online Registry (METeOR).
On 21 March 2022, the Australian Commission on Safety and Quality in Health Care, the Aged Care Quality and Safety Commission and the NDIS Quality and Safeguards Commission have launched the Joint Statement on the important issue of inappropriate use of psychotropic medicines with people with disability and older people as a form of restrictive practice, and committed to collaborative action to reduce it.
This issue includes items on COVID-19, digital mental health standards, primary care, digital health, disruptive behaviour and more.
Also covered are the latest issues of the Journal of Patient Safety and Risk Management and BMJ Quality & Safety, along with online first papers from BMJ Quality & Safety and the International Journal for Quality in Health Care and the latest from the UK’s NICE.